Cover Image

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis

This post hoc analysis examined SCORing Atopic Dermatitis (SCORAD) outcomes in 471 paediatric patients (children age 6-<12 years, n = 304; adolescents age 12-<18 years, n = 167) with atopic dermatitis treated with dupilumab, ± topical corticosteroids, in two 16-week phase 3 randomized controll...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andreas Wollenberg (Author), Danielle Marcoux (Author), Jonathan I. Silverberg (Author), Valeria Aoki (Author), Eulalia Baselga (Author), Haixin Zhang (Author), Noah A. Levit (Author), Alain Taieb (Author), Ana B. Rossi (Author)
Format:	Book
Published:	Medical Journals Sweden, 2022-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023)

Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
by: Jonathan I. Silverberg, et al.
Published: (2021)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
by: Surina Frey, et al.
Published: (2021)

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
by: Mette Deleuran, et al.
Published: (2021)

Dupilumab normalizes correlates of lysosomal function in atopic dermatitis
by: Christina Bürgler, et al.
Published: (2024)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
by: Elaine C. Siegfried, et al.
Published: (2023)

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
by: Shiyu Zhang, et al.
Published: (2023)

Dupilumab in atopic dermatitis patients with chronic hepatitis B
by: Masako Matsutani, et al.
Published: (2022)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023)

Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report
by: Shintaro Takeoka, et al.
Published: (2021)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
by: Shoko Miyamoto, et al.
Published: (2022)

Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
by: Lina U. Ivert, et al.
Published: (2019)

Conjunctivitis as a common adverse effect of dupilumab in atopic dermatitis
by: Mikołaj Cichoń, et al.
Published: (2023)

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis
by: Shinji Mitsuyama, et al.
Published: (2023)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023)

Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis
by: Emilie Fowler, et al.
Published: (2019)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
by: Marco Ferrari, et al.
Published: (2023)

Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
by: Susumu Ichiyama, et al.
Published: (2021)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
by: Aakaash Varma, BA, et al.
Published: (2020)

A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
by: Wang M, et al.
Published: (2024)

Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitis
by: Mohamed A. Kamal, et al.
Published: (2022)

Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
by: I. S. Krysanov, et al.
Published: (2020)

443 Dupilumab for Children and Adolescents with Atopic Dermatitis: An Asian Perspective
by: Shi Yun Chia, et al.
Published: (2021)

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis
by: Matthias Augustin, et al.
Published: (2023)

A risk-scoring system to predict dupilumab-associated ocular surface disease in patients with atopic dermatitis
by: Sunyoung Shim, et al.
Published: (2024)

Evaluation of the Impact of Serum Vitamin D Levels on the Scoring Atopic Dermatitis Index in Pediatric Atopic Dermatitis
by: Fatih Çiçek, et al.
Published: (2023)

Dupilumab‐related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London
by: Anjali Rampersad, et al.
Published: (2024)

Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab
by: Mingxia Wang, et al.
Published: (2022)

Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report
by: Lama Alotaibi, et al.
Published: (2021)

Dupilumab for atopic dermatitis treatment: A single-center retrospective study
by: Gülbin Yaşar, et al.
Published: (2022)

Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis,
by: Camilla Chello, et al.
Published: (2021)